Concentra Group Holdings Parent Q2 Earnings Call Highlights

Impact · against what's priced in

Concentra's Q2 results show strong operational execution with 22.5% EBITDA growth and a significant jump in free cash flow to $121 million. The planned CEO succession and guidance for continued center expansion provide a stable growth trajectory and positive catalyst for the stock.

CON+0.60

No priced-in read yet

In context

Adjusted EBITDA rose 22.5% to $140.9 million with margins expanding to 23.3%, while free cash flow nearly doubled to $121 million. A planned leadership transition to CFO Matt DiCanio on November 1st suggests operational continuity.

Read from the article alone

• revenue growth▲2%
• cash flow
• earnings
• healthcare
• CON
• ceo succession
• management change
• occupational health
• workers compensation